PET in cervical cancer – pro
Lay Summary: PET has become an accepted tool for determining the extent of newly diagnosed cervical cancer and for following effects of treatment
NCCN recently (8/07) revised its staging recomendations and lists PET as a recommended staging modlity. Positron-emission tomography (PET) scan is no longer optional for ≥ stage IB2 disease and is now recommended as part of the workup. Whole-body positron emission tomography (PET) completed after cervical cancer treatment predicts outcome in a recent study.
Grigsby PW, Siegel BA, Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. Journal of Clinical Oncology. 19(17), 3745-3749, Sept. 1, 2001
http://www.nccn.org/professionals/physician_gls/PDF/cervical.pdf
Schwarz JK, Siegel BA, Dehdashti F, Grigsby PW. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA. 2007 Nov 21;298(19):2289-95.
JHuang KG, Ng KK, Tang SG, Chang YC, Hsueh S, Tsai CS, Hong JH, Lin CT, Chao A, Ma SY, Lin WJ, Fu YK, Fan CC, Lai CH. Defining the priority of using 18F-FDG PET for recurrent cervical cancer.Yen TC, See LC, Chang TC, Nucl Med. 2004 Oct;45(10):1632-9.Comment in:
J Nucl Med. 2004 Oct;45(10):1602-4.